Variant report
Variant | nsv1027246 |
---|---|
Chromosome Location | chr8:9852712-9882476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260093 | chromatin interactions |
ENSG00000175806 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183233078 | chr8:9852785-9852786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189055880 | chr8:9852823-9852824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17737587 | chr8:9852825-9852826 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs34244806 | chr8:9852849-9852850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs80134250 | chr8:9852859-9852860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73537260 | chr8:9852861-9852862 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs565518178 | chr8:9852872-9852873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs77073845 | chr8:9852878-9852879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs78668745 | chr8:9852907-9852908 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549797017 | chr8:9852917-9852918 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567505781 | chr8:9852918-9852919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75697727 | chr8:9852923-9852924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35415101 | chr8:9852961-9852962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553610787 | chr8:9852966-9852967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs36049399 | chr8:9852982-9852983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139333039 | chr8:9852993-9852994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192842152 | chr8:9853053-9853054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538784829 | chr8:9853064-9853065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs573742234 | chr8:9853151-9853152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368492773 | chr8:9853176-9853177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568761650 | chr8:9853192-9853193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537706153 | chr8:9853217-9853218 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1553665 | chr8:9853268-9853269 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569279832 | chr8:9853295-9853296 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141584188 | chr8:9853319-9853320 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574318368 | chr8:9853346-9853347 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150502854 | chr8:9853420-9853421 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558263699 | chr8:9853433-9853434 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577677881 | chr8:9853471-9853472 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138384885 | chr8:9853487-9853488 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185436214 | chr8:9853596-9853597 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187905444 | chr8:9853617-9853618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565431218 | chr8:9853634-9853635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575804393 | chr8:9853697-9853698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573082951 | chr8:9853714-9853715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544541477 | chr8:9853753-9853754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs193008916 | chr8:9853777-9853778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs35714584 | chr8:9853798-9853799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs666079 | chr8:9853853-9853854 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs183599673 | chr8:9853860-9853861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76349117 | chr8:9853867-9853868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78648757 | chr8:9853868-9853869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74744278 | chr8:9853869-9853870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs76505190 | chr8:9853871-9853872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149261133 | chr8:9853889-9853890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532469578 | chr8:9853890-9853891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs552259583 | chr8:9853940-9853941 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74384928 | chr8:9853971-9853972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538060970 | chr8:9853979-9853980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs574005773 | chr8:9853992-9853993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:9842400-9855000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:9852800-9853200 | Enhancers | HSMMtube | muscle |
3 | chr8:9853000-9853600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr8:9853000-9853800 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr8:9853000-9853800 | Enhancers | A549 | lung |
6 | chr8:9853200-9853600 | Enhancers | Duodenum Mucosa | Duodenum |
7 | chr8:9853200-9853600 | Enhancers | Small Intestine | intestine |
8 | chr8:9853200-9853600 | Flanking Active TSS | HSMMtube | muscle |
9 | chr8:9853400-9853600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr8:9853400-9854000 | Enhancers | HSMM | muscle |
11 | chr8:9853600-9854000 | Enhancers | HSMMtube | muscle |
12 | chr8:9854800-9855000 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr8:9854800-9855000 | Bivalent Enhancer | Right Ventricle | heart |
14 | chr8:9855000-9855200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr8:9855000-9855200 | Bivalent Enhancer | Fetal Stomach | stomach |
16 | chr8:9855000-9856000 | Enhancers | Fetal Brain Male | brain |
17 | chr8:9855200-9855600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr8:9855400-9855600 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
19 | chr8:9857200-9857400 | Enhancers | Fetal Brain Male | brain |
20 | chr8:9867600-9870600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr8:9870000-9871600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
22 | chr8:9870200-9871000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr8:9870600-9870800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr8:9870600-9870800 | Bivalent Enhancer | Esophagus | oesophagus |
25 | chr8:9872200-9874600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
26 | chr8:9872400-9873200 | Enhancers | HMEC | breast |
27 | chr8:9872600-9873000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
28 | chr8:9872600-9873200 | Enhancers | NHEK | skin |
29 | chr8:9880600-9881000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
30 | chr8:9880600-9881000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
31 | chr8:9880600-9881000 | Enhancers | HMEC | breast |